Post Doc - Open Rank - Wolfe Lab

UMass Chan Medical School; Worcester (MA); On-site; USD 55,000 - 75,000; Full time

Job summary

UMass Chan Medical School in Worcester is hiring a Postdoctoral researcher to develop genome editing reagents targeting muscular dystrophies and cancer. The role involves utilizing cutting-edge genome engineering techniques and evaluating off-target effects in vivo.

Applicants need a Ph.D. in a related field and strong communication skills. Experience with genome editing and deep-sequencing technologies is advantageous. The position provides a unique opportunity to contribute to innovative research and engage with the scientific community.

Qualifications

• Ph.D. in a relevant field required.
• Strong communication skills essential.
• Prior experience with genome editing systems preferred.

Responsibilities

• Develop therapeutic genome editing reagents for muscular dystrophies and cancer.
• Utilize genome-wide techniques for assessing off-target events.

Skills

Strong oral and written communication skills

Experience with genome editing systems

Cell culture experience

Deep-sequencing technologies

Mouse disease models

Education

Ph.D. in biology, biochemistry, chemistry, or related biomedical science

Job description

Development of genome editing reagents for muscular dystrophy and cancer

The Wolfe Laboratory will be filling a Postdoctoral Position to develop therapeutic genome editing reagents for muscular dystrophies and cancer. These projects will focus on:

• Development of prime editing reagents with high activity and specificity for the precise correction of common pathogenic mutations associated with Limb Girdle Muscular Dystrophy.
• Development of genome editing reagents for selective killing of cancer cells harboring gene amplifications.
• Utilization of unbiased genome-wide techniques for assessing off‑target events and other genomic alterations potentially associated with genome editing.
• Translation of the developed genome editing reagents to clinical application through in vivo safety and efficacy studies in relevant mouse models.

These studies will expose the successful candidate to cutting‑edge genome editor engineering approaches and the delivery of these reagents in vivo via lipid nanoparticles. The candidate will also learn deep‑sequencing approaches to evaluate off‑target editing within the genome and will have the opportunity to participate in meetings and conferences associated with genome editing and gene therapy, broadening their exposure to cutting‑edge research within the field.

Applicants should have a Ph.D. in biology, biochemistry, chemistry or a related biomedical science. In addition, the candidate must possess strong oral and written communication skills and be eager to present research results at national meetings. Prior experience with genome editing systems, cell culture, deep‑sequencing technologies and mouse disease models is advantageous but not required.

Applicants should send a letter (via email) describing their current research activities and their interest in this position, a CV (including publications) and contact information for three references, including your Ph.D. advisor.

Address letters to Scot Wolfe ([e-mail]).

University of Massachusetts Chan Medical School

Department of Molecular, Cell, and Cancer Biology

364 Plantation Street, LRB Room 619

Worcester, MA 01605

Further details about the Wolfe laboratory can be found at: https://www.umassmed.edu/Wolfe-Lab/, https://profiles.umassmed.edu/display/133161

UMass Chan Medical School is committed to being an equal opportunity and affirmative action employer and recognizes the power of a diverse community. We encourage applications from protected veterans, individuals with disabilities and those with varied experiences, perspectives and backgrounds to consider UMass Chan Medical School as their employer of choice. The University of Massachusetts Chan Medical School welcomes all qualified applicants and complies with all state and federal anti‑discrimination laws.